Effects of SAMe, MTA, miR-34a and miR-34b on MAT2A and MAT2B

MAT2A WT and Val11 expression in COS-1 cells treated with 10 mM 3MA (A)

Myostatin signals through miR-34a to regulate Fndc5 expression and browning of white adipocytes

Mir-34: A New Weapon Against Cancer? - ScienceDirect

miR-34a negatively regulates cell cycle factor Cdt2/DTL in HPV infected cervical cancer cells, BMC Cancer

microRNA-34 family: From mechanism to potential applications - ScienceDirect

circFANCA accelerates the malignant process of OSCC by modulating miR-34a/PA28γ signaling - ScienceDirect

MiR-34a-3p alters proliferation and apoptosis of meningioma cells in vitro and is directly targeting SMAD4, FRAT1 and BCL2 - Figure f5

Human MAT2A and MAT2B genetic polymorphisms observed during

Base-pair conformational switch modulates miR-34a targeting of Sirt1 mRNA

MAT2A WT and Val11 expression in COS-1 cells treated with 10 mM 3MA (A)

MiR-34 and MiR-200: Regulator of Cell Fate Plasticity and Neural Development

Epigenomes, Free Full-Text

A first-in-class fully modified version of miR-34a with outstanding stability, activity, and anti-tumor efficacy

Andrea FLORIS, Research Fellow, Research Fellow, Cedars-Sinai Medical Center, Los Angeles, Department of Medicine

Maria TOMASI, Professor (Assistant), Molecular Pathology, Ph.D, Cedars-Sinai Medical Center, Los Angeles, Department of Medicine